Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

Carlo Visco; Maria C. Tisi; Maria Chiara Tisi; Andrea Evangelista; Alice Di Rocco; Anna-Katharina Zoellner; Vittorio R. Zilioli; Stefan Hohaus; Roberta Sciarra; Alessandro Re; Cristina Tecchio; Annalisa Chiappella; Lucia Morello; Guido Gini; Luca Nassi; Tommasina Perrone; Anna L. Molinari; Alberto Fabbri; Maria C. Cox; Erica Finolezzi; Simone Ferrero; Benedetta Puccini; Isabel Alvarez De Celis; Annalisa Arcari; Dario Marino; Michele Merli; Francesco Piazza; Massimo Gentile; Marino Gentile; Matteo Pelosini; Giacomo Loseto; Olivier Hermine; Martin Dreyling; Marco Ruggeri; Maurizio Martelli; Eva Hoster; Umberto Vitolo

doi:10.1111/bjh.15643

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

Carlo Visco, Maria C. Tisi, Maria Chiara Tisi, Andrea Evangelista, Alice Di Rocco, Anna-Katharina Zoellner, Vittorio R. Zilioli, Stefan Hohaus, Roberta Sciarra, Alessandro Re, Cristina Tecchio, Annalisa Chiappella, Lucia Morello, Guido Gini, Luca Nassi, Tommasina Perrone, Anna L. Molinari, Alberto Fabbri, Maria C. Cox, Erica FinolezziSimone Ferrero, Benedetta Puccini, Isabel Alvarez De Celis, Annalisa Arcari, Dario Marino, Michele Merli, Francesco Piazza, Massimo Gentile, Marino Gentile, Matteo Pelosini, Giacomo Loseto, Olivier Hermine, Martin Dreyling, Marco Ruggeri, Maurizio Martelli, Eva Hoster, Umberto Vitolo

Risultato della ricerca: Contributo in rivista › Articolo in rivista

16 Citazioni (Scopus)

Abstract

N/A

Lingua originale	English
pagine (da-a)	940-944
Numero di pagine	5
Rivista	British Journal of Haematology
Volume	185
DOI	https://doi.org/10.1111/bjh.15643
Stato di pubblicazione	Pubblicato - 2019

Keywords

allogeneic transplant
cytarabine
mantle cell lymphoma
prognosis
refractory

Accesso al documento

10.1111/bjh.15643

Altri file e collegamenti

Cita questo

Visco, C., Tisi, M. C., Tisi, M. C., Evangelista, A., Di Rocco, A., Zoellner, A.-K., Zilioli, V. R., Hohaus, S., Sciarra, R., Re, A., Tecchio, C., Chiappella, A., Morello, L., Gini, G., Nassi, L., Perrone, T., Molinari, A. L., Fabbri, A., Cox, M. C., ... Vitolo, U. (2019). Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death. British Journal of Haematology, 185, 940-944. https://doi.org/10.1111/bjh.15643

@article{5801ac32f1024b9cb833a68d2efea8c0,

title = "Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death",

abstract = "N/A",

keywords = "allogeneic transplant, cytarabine, mantle cell lymphoma, prognosis, refractory, allogeneic transplant, cytarabine, mantle cell lymphoma, prognosis, refractory",

author = "Carlo Visco and Tisi, {Maria C.} and Tisi, {Maria Chiara} and Andrea Evangelista and {Di Rocco}, Alice and Anna-Katharina Zoellner and Zilioli, {Vittorio R.} and Stefan Hohaus and Roberta Sciarra and Alessandro Re and Cristina Tecchio and Annalisa Chiappella and Lucia Morello and Guido Gini and Luca Nassi and Tommasina Perrone and Molinari, {Anna L.} and Alberto Fabbri and Cox, {Maria C.} and Erica Finolezzi and Simone Ferrero and Benedetta Puccini and {Alvarez De Celis}, Isabel and Annalisa Arcari and Dario Marino and Michele Merli and Francesco Piazza and Massimo Gentile and Marino Gentile and Matteo Pelosini and Giacomo Loseto and Olivier Hermine and Martin Dreyling and Marco Ruggeri and Maurizio Martelli and Eva Hoster and Umberto Vitolo",

year = "2019",

doi = "10.1111/bjh.15643",

language = "English",

volume = "185",

pages = "940--944",

journal = "British Journal of Haematology",

issn = "1365-2141",

publisher = "Blackwell Science Limited:PO Box 88, Oxford OX2 0NE United Kingdom:011 44 1865 776868, 011 44 1865 206038, EMAIL: [email protected], INTERNET: http://www.blackwell-science.com, Fax: 011 44 1865 721205",

}

Visco, C, Tisi, MC, Tisi, MC, Evangelista, A, Di Rocco, A, Zoellner, A-K, Zilioli, VR, Hohaus, S, Sciarra, R, Re, A, Tecchio, C, Chiappella, A, Morello, L, Gini, G, Nassi, L, Perrone, T, Molinari, AL, Fabbri, A, Cox, MC, Finolezzi, E, Ferrero, S, Puccini, B, Alvarez De Celis, I, Arcari, A, Marino, D, Merli, M, Piazza, F, Gentile, M, Gentile, M, Pelosini, M, Loseto, G, Hermine, O, Dreyling, M, Ruggeri, M, Martelli, M, Hoster, E & Vitolo, U 2019, 'Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death', British Journal of Haematology, vol. 185, pagg. 940-944. https://doi.org/10.1111/bjh.15643

TY - JOUR

T1 - Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

AU - Visco, Carlo

AU - Tisi, Maria C.

AU - Tisi, Maria Chiara

AU - Evangelista, Andrea

AU - Di Rocco, Alice

AU - Zoellner, Anna-Katharina

AU - Zilioli, Vittorio R.

AU - Hohaus, Stefan

AU - Sciarra, Roberta

AU - Re, Alessandro

AU - Tecchio, Cristina

AU - Chiappella, Annalisa

AU - Morello, Lucia

AU - Gini, Guido

AU - Nassi, Luca

AU - Perrone, Tommasina

AU - Molinari, Anna L.

AU - Fabbri, Alberto

AU - Cox, Maria C.

AU - Finolezzi, Erica

AU - Ferrero, Simone

AU - Puccini, Benedetta

AU - Alvarez De Celis, Isabel

AU - Arcari, Annalisa

AU - Marino, Dario

AU - Merli, Michele

AU - Piazza, Francesco

AU - Gentile, Massimo

AU - Gentile, Marino

AU - Pelosini, Matteo

AU - Loseto, Giacomo

AU - Hermine, Olivier

AU - Dreyling, Martin

AU - Ruggeri, Marco

AU - Martelli, Maurizio

AU - Hoster, Eva

AU - Vitolo, Umberto

PY - 2019

Y1 - 2019

N2 - N/A

AB - N/A

KW - allogeneic transplant

KW - cytarabine

KW - mantle cell lymphoma

KW - prognosis

KW - refractory

KW - allogeneic transplant

KW - cytarabine

KW - mantle cell lymphoma

KW - prognosis

KW - refractory

UR - http://hdl.handle.net/10807/141173

UR - http://onlinelibrary.wiley.com/journal/10.1111/(issn)1365-2141

U2 - 10.1111/bjh.15643

DO - 10.1111/bjh.15643

M3 - Article

SN - 1365-2141

VL - 185

SP - 940

EP - 944

JO - British Journal of Haematology

JF - British Journal of Haematology

ER -

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo